Kaiser Permanente alongside with UCSF plans for genetic analyses of an unprecedented 100,000 older Californians, the Technology Review writes in Massive Gene Database Planned in California The effort will make use of existing saliva samples taken from California patients, whose average age is 65. Their DNA will be analyzed for 700,000 genetic variations called single-nucleotide… Continue reading Aging-centric genetic health database in California: 100k people, ~65yrs, 700k SNPs, telomeres too
I ordered my first commercial genetic profile from 23andMe on the 9th of September online, FedExed my 2 ml saliva from Budapest to 23andMe, Mountain View on the 12th of September. I got the results today. That said within 3 weeks since the birth of the idea I purchased more than 500 000 SNPs of… Continue reading Mountain View – Budapest: 20 days to get my 23andMe profile!
I try to cover some interesting, sciencey points on the conference in later posts, right now just a brief, subjective human- and strategy focused summary: Congrats to Aubrey de Grey and the team, everything went well and if finally a worldwide consensus is around the corner claiming that robust healthy lifespan extension is technologically possible… Continue reading Understanding Aging Conference is over but it is the end of the beginning
This is how my Macbook saw Aubrey de Grey’s talk exactly 1 week ago on the AGING preconference at UCLA.
It’s my first real encounter with a situation in which the officials of the state of California are clearly against innovation for financial reasons obvious enough (is enough): Wired Science, Alexis Madrigal, upcoming BioBarCamper: Exclusive: DNA Tester Reveals Cease-and-Desist Letter Wired.com has obtained a copy of the cease-and-desist letter sent to Navigenics by the state… Continue reading Innovation stop: “All they’ve done is created an extra billing event for the doctor”
It’s official: The California Department of Public Health wants practicing physicians (many of them prehistorically, sorry, traditionally trained) to be the patres familias in issues between personal genetic test takers and direct-to-consumer personal genetic testing start-ups while declining the test takers’ right to get familiar with their own genetic makeup and risks by their own.… Continue reading Future stop: California health officials against personal genetics risk-takers
MIMvista Corp. is a third party software provider for PET and PET/CT display. Go SciPhone, go! source: Gizmodo Live Coverage
Consumer-Enabled Research, the second goal of pioneering personalized genetics company 23andMe, reached its first generation with the launch of 23andWe. From BusinessWire: “23andWe marks a new approach to genetics research. By directly involving 23andMe customers in the company’s research projects, the goal is to conduct large-scale studies powered by a web-based community of diverse individuals… Continue reading 23andWe follows 23andMe: First generation of Consumer-Enabled Research
The O’Reilly AlphaTech Ventures Startup Camp is a nice option for the emerging personalized genomics companies or any web-related biotech startups to communicate and cooperate with alpha geeks and early technology adopters. Tim O’Reilly writes: The Thursday and Friday (July 10-11) before this year’s Foo Camp in Sebastopol July 11-13, O’Reilly AlphaTech Ventures will be… Continue reading O’Reilly Startup Camp for geeky biotech startups too!
The title question is my million (not billion yet) dollar question for this year. Arthur Levinson is a board member of Google (Apple too) and in his leftover time he is the CEO of the most successful biotech company so far, that’s Genentech. I would be curious to hear about his biotech-related activity as a… Continue reading What is Genentech CEO Art Levinson doing for biotech as a Google board member?
The O’Reilly Emerging Technology Conference (ETech) is on and this year they had a growing number of biotech related sessions. Fellow SciFoo Campers like Hugh Rienhoff and Timo Hannay, Makers like Phil Torrone and Limor Fried, Brain Hackers like Ed Boyden are visiting and many more.
Looks like the scientist coalition behind healthy life extension is widening. In line with that the question Why was life extension ruled out of the 14 Grand Engineering Challenges? is fading away. Here is an Aubrey de Grey message from my mailbox: All details, including forms for abstract submission and online registration, are at the… Continue reading Understanding Aging Conference in L.A.: de Grey, Conboy, Wagers and many others…
Finally back from my Bay Area trip, the workshop I participated turned out to be very stimulating in terms of people and ideas. Also visiting The Blood Knot performance at the American Conservatory Theater and having a drink with Monya&Dan were absolutely delightful. I missed my flight on Saturday, so I slept in LA (and… Continue reading Bubble City’s South Park: geek tourism
Leaving New Orleans for the Bay Area for the next 3 days. I am visiting a quite enigmatic workshop in Palo Alto on Feb 22, then I am in San Francisco downtown on Friday evening and Saturday AM. If anybody would like to meet me, I am available there on Saturday near Union Square, just… Continue reading Off to Palo Alto, CA
The personal genomics service 23andMe just launched publicly a corporate blog called The Spittoon that has been internally up for a few weeks. It is a new chapter in biotech corporate blogging. Just like the web page of 23andMe, The Spittoon’s WordPress blog platform, the concept and design is excellent: amongst others you can find… Continue reading The Spittoon: the eminent corporate blog of 23andMe and Consumer Enabled Research
Different attitudes, same endeavors. 1. The folks at the California Institute of Regenerative Medicine (CIRM) started to offer grants for biotech companies up to $55,000 out of the 3 billion ‘hope’ dollars. San Diego Union Tribune: Industry and academia team up: For the first time in its three-year existence, the state taxpayer-funded stem cell institute… Continue reading CIRM and NIH stem cell grants to the biotech industry
According to the newest Request For Applications (RFA) of the California Institute for Regenerative Medicine (CIRM), the New Cell Line Awards will support two categories of research: Category 1: Derivation of new hESC lines using excess or rejected early stage human embryos generated by in vitro fertilization. Category 2: Derivation of pluripotent human stem cell… Continue reading California embryonic stem cell dollars: beyond the embryonic phase
After Jobs-Wozniak, Yang-Filo, Brin-Page, it’s time to memorize the names of the co-founders of 23andMe, the first personalized genome service, who are turning the tech establishment into a biotech mode. The new faces of Silicon Valley: the age of Blue Jeans/Black T-Shirt co-founder computer nerds is over, welcome to the era of stylish, well-dressed genetics-savvy… Continue reading The new faces of Silicon Valley: biotech-savvy co-founders Avey-Wojcicki
Detailed article in the New York Times on the early experience of decoding the genetic code and interpreting the customers’ DNA via the service of 23andMe. The buzz name of the project: personalized genetics/genomics. Although other companies are mentioned briefly, the focus is clearly on 23andMe. The basics: get rid of a thousand bucks (sorry,… Continue reading Spit a big in a tube, search with Genome Explorer: the 23andMe way
In the unique state of California there is now an offer for individuals to place orders from October 3 during a $250 million sale of state debt to fund embryonic stem-cell research. The minimum bet is $5,000 and over 1 million you need special permission (just like buying more than 2 iPhones in the early… Continue reading United State of California: buy bonds in stem cell research
Let’s emphasize the role of good food in efficient brainstormings (just like SciFoo was) now and ever. Bad feelings were simply excluded about the food at the Googleplex. I shot these pictures with myPhone. Thanks, chef!
The Buck Institute in Novato, California is a rich private research center focusing on aging with the mission of “extending the healthy years of life”. They have a real interdisciplinary staff, exactly the one that is needed for studying aging, which is a notoriously multifactorial, multicausal, atypical and complex biological phenomenon. One of the faculty… Continue reading Ask a good scientist in a San Francisco Cafe: The Reality of Age Research
SciFoo is over, and I’ve just arrived back to New Orleans from SF. First of all: a big thanks for the organizers (Chris DiBona, Timo Hannay, Tim O’Reilly, Google, Nature, O’Reilly) and campers, it was really the highest end. Here is a quick SciFoo key terms summary (photos, detailed accounts later): “scientific data” One of… Continue reading SciFoo Camp, 2007: data (Google) publishing (Nature) geeks (O’Reilly)
SciFoo is coming, so I take my flight tomorrow from humid and subtropical New Orleans (running experiment terminated this afternoon, things in liquid nitrogen for downstream processing) to the cold San Francisco. Besides the Googleplex I am visiting Berkeley, Stanford, UCSF and as many of the central places of high tech culture (you know, the… Continue reading Going to San Francisco and the Valley, SciFoo preparations
I’ve just realized that Mr. Governator’s official website is the most visible outbound link on the website of The California Institute for Regenerative Medicine. That is actually a 3 billion dollar link.
This slide comes from the presentation of Google Fellow Jeff Dean on Seattle Conference on Scalability, entitled Abstractions for Handling Large Datasets. (The title Google Fellow seems to me as something similar in rank to a full professorship at Stanford.) Here is the presentation itself embedded:
The sea squirt can regenerate its whole body from the vasculature. I asked Ayelet Voskoboynik, postdoctoral fellow from the Weissman lab, Stanford University, to tell us how. Their findings were published in a recent paper, entitled Striving for normality: whole body regeneration through a series of abnormal generations (FASEB Journal, 2007 May;21(7):1335-44.) Read the whole… Continue reading Abnormal whole body regeneration from the vasculature at the sea squirt
Earlier: BioTech(nically), Business 2.0’s new biotech blog
Aubrey de Grey‘s presentation in Google Tech Talk series at the Googleplex, Mountain View, May 29, 2007 (Thanks, Russell Whitaker). More on Aubrey on Pimm: Content of Ending Aging, Aubrey de Grey’s coming life extension book 3 Edmonton Aging (Life Extension) Symposium videos Blogterview with Aubrey de Grey: life extension stories
Geoffrey P. Lomax, Zach W. Hall, Bernard Lo: Responsible Oversight of Human Stem Cell Research: The California Institute for Regenerative Medicine’s Medical and Ethical Standards Source: Plos blog, In the May issue of PLoS Medicine
News: “Both Jobs and Gates are slated to jointly discuss the digital revolution’s history and future at The Wall Street Journal’s D: All Things Digital conference on Wednesday.” Comment: Instead of Mr. Gates I’d be eager to see those 2 guys on the right discussing the future of all things digital (especially the future of… Continue reading Jobs/Gates on the history, Jobs/other guys on the future of digital revolution
Builders, Hackers, Do-It-Yourselfers are gathering around this weekend at the most visible embodiment of the Maker spirit, the Maker Faire 2007 at San Mateo Fairgrounds, California. I remember the inquisitive and incredulous eyes of the traditional tech makers, coders, engineers while presenting my placental stem cell project at Euro Maker Faire last year. Now imagine… Continue reading Second Annual Maker Faire this weekend and expecting the First BioMaker Faire…
While people in California can think they are in the centre of the (embryonic) stem cell universe due to Proposition 71’s $3 Billion and the invasion of good scientists into the West Coast, Massachusetts academic and biotech people also are thinking along those lines, so state officials quickly set up a $1.25 Billion package for… Continue reading Stem Cell Cup: California Embryonics vs Massachusetts Oldies: $3 vs $1.25 Billion
Bodyhack, Wired’s pioneer biotech and stem cell focused blog is folding into Wired Science Blog. Thank you Kristen et al. The bodyhacknorati profile:
Press Release of California Institute of Regenerative Medicine: LOS ANGELES, March 16, 2007 – “Just a month after approving nearly $45 million for embryonic stem cell research, California’s stem cell agency authorized another $75.7 million in additional funds for established scientists at 12 non-profit and academic institutions.” With this latest round of CIRM donation more… Continue reading Competitive strength of California Institutions measured by stem cell grants
Once upon a time in 2005 I wrote an article on Wired magazine published in a language you probably do not understand. This photo was shot by Daniel Nemeth in my appartment, so if you are curious, you can see three little pieces of carpet in my living room. Have a nice weekend!
Bodyhack, Wired’s stem cell focused biotech group blog, written at least by Kristen Philipkoski, Brandon Keim, Randy Dotinga, Mark Woodman and Scott Carney, has got a new dress: In recent weeks Bodyhack has paid more attention to other Wired blogs and sexuality as well, so content can go through a radical change too. I hope… Continue reading Bodyhack redesigned
Such a Californian story: Lorry I. Lokey, the founder of Business Wire will give a minimum of $33 million to help build a home for Stanford’s Institute for Stem Cell Biology and Regenerative Medicine. Lokey says: “The important thing to me is that stem cells might not only extend life, but also improve the quality… Continue reading 80 year old Lokey’s $33 million donation for Stanford Stem Cell Labs
Read this nice and brand conscious weekend off story on Official Google Mac Blog. Scott Knaster, Mac Team Technical Writer at Google organized a trip for a “gang of new Mac fans at Google“ from Mountain View to Apple headquarters, Cupertino. At the Caffe Macs they were eating a Google-like terrific food, but not for… Continue reading Mac Googlers at Apple Headquarters: from Mountain View to Cupertino